Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
54.32
-2.78 (-4.87%)
May 7, 2026, 9:31 AM EDT - Market open
Vaxcyte Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$88.25
Upside
+62.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Maintains $85 → $89 | Strong Buy | Maintains | $85 → $89 | +63.84% | Feb 26, 2026 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $116 | Strong Buy | Reiterates | $116 | +113.55% | Feb 2, 2026 |
| Needham | Needham | Strong Buy Maintains $90 → $110 | Strong Buy | Maintains | $90 → $110 | +102.50% | Jan 7, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $85 | Strong Buy | Reiterates | $85 | +56.48% | Nov 10, 2025 |
| BTIG | BTIG | Strong Buy Maintains $160 → $85 | Strong Buy | Maintains | $160 → $85 | +56.48% | Oct 16, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $38 | Hold | Initiates | $38 | -30.04% | Sep 12, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 22, 2025 |
| Needham | Needham | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +65.68% | Apr 8, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $138 → $100 | Strong Buy | Maintains | $138 → $100 | +84.09% | Apr 1, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $157 → $137 | Strong Buy | Maintains | $157 → $137 | +152.21% | Apr 1, 2025 |
| Needham | Needham | Strong Buy Maintains $140 → $90 | Strong Buy | Maintains | $140 → $90 | +65.68% | Apr 1, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +194.55% | Mar 12, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +194.55% | Feb 26, 2025 |
| Needham | Needham | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +157.73% | Feb 26, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $160 | Strong Buy | Reiterates | $160 | +194.55% | Feb 24, 2025 |
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | -74.23% | Feb 11, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.